Potential COVID-19 vaccine produced at Catalent’s Madison facility

Catalent, Inc.’s biomanufacturing facility in Madison.
Catalent, Inc.’s biomanufacturing facility in Madison.

Last updated on June 24th, 2020 at 12:07 pmAs researchers race to develop a vaccine for COVID-19, production on one potential single-shot vaccine is underway at Catalent, Inc.’s biomanufacturing facility in Madison. Somerset, New Jersey-based Catalent and San Diego-based Arcturus Therapeutics Holdings Inc. are partnering to manufacture a COVID-19 mRNA vaccine candidate at Catalent Biologics’

Want to Read the Entire Article?

Become a BizTimes Insider to get immediate access to our subscriber-only content and much more.

Become an Insider Now

Already an Insider? Log In

Sign up for BizTimes Daily Alerts

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

No posts to display